» Articles » PMID: 16770161

The Emerging Use of TNF-alpha Inhibitors in Orbital Inflammatory Disease

Overview
Specialty Ophthalmology
Date 2006 Jun 14
PMID 16770161
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Orbital inflammatory pseudotumor: new advances in diagnosis, pathogenesis, and treatment.

Fang Y, Shen B, Dai Q, Xie Q, Wu W, Wang M Eur J Med Res. 2023; 28(1):395.

PMID: 37794419 PMC: 10548690. DOI: 10.1186/s40001-023-01330-0.


New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.

He Q, Dong H, Gong M, Guo Y, Xia Q, Gong J Front Pharmacol. 2022; 13:862831.

PMID: 35462920 PMC: 9020194. DOI: 10.3389/fphar.2022.862831.


Therapeutic difference between orbital decompression and glucocorticoids administration as the first-line treatment for dysthyroid optic neuropathy: a systematic review.

Xu M, Pan Z, Tu Y, Tao H, Shi K, Wu W Int J Ophthalmol. 2021; 14(7):1107-1113.

PMID: 34282398 PMC: 8243185. DOI: 10.18240/ijo.2021.07.21.


Fibrosing Inflammatory Pseudotumor Presenting as Cranial Neuropathy.

Miyawaki E, Hsu L, Bhattacharyya S, OHare M, Roy A, Kett L Case Rep Neurol. 2020; 12(2):247-254.

PMID: 32774282 PMC: 7383149. DOI: 10.1159/000507920.


Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking.

Zhang Y, Li X, Guo C, Dong J, Liao L BMC Complement Med Ther. 2020; 20(1):229.

PMID: 32689994 PMC: 7372882. DOI: 10.1186/s12906-020-03022-2.